Kanda, T., Yasui, S., Nakamura, M., Nakamoto, S., Takahashi, K., Wu, S., . . . Kato, N. (2018). Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events. Oncotarget.
Chicago Style CitationKanda, Tatsuo, et al. "Successful Retreatment With Grazoprevir and Elbasvir for Patients Infected With Hepatitis C Virus Genotype 1b, Who Discontinued Prior Treatment With NS5A Inhibitor-including Regimens Due to Adverse Events." Oncotarget 2018.
Cita MLAKanda, Tatsuo, et al. "Successful Retreatment With Grazoprevir and Elbasvir for Patients Infected With Hepatitis C Virus Genotype 1b, Who Discontinued Prior Treatment With NS5A Inhibitor-including Regimens Due to Adverse Events." Oncotarget 2018.